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Nanoparticle	charge-transfer	interactions	induce	surface	
dependent	conformational	changes	in	apolipoprotein	biocorona		
Achyut	J	Raghavendraa,	Nasser	Alsalehb,	Jared	M.	Brownb*	and	Ramakrishna	Podilaa,	c*.	
Upon	 introduction	 into	 a	 biological	 system,	 engineered	 nanomaterials	 (ENMs)	 rapidly	 associate	 with	 a	 variety	 of	
biomolecules	such	as	proteins	and	lipids	to	form	a	biocorona.	The	presence	of	‘biocorona’	influences	nano-bio	interactions	
considerably,	and	could	ultimately	result	in	altered	biological	responses.	Apolipoprotein	A-I	(ApoA-I),	the	major	constituent	
of	 high-density	 lipoprotein	 (HDL),	 is	 one	 of	 the	most	 prevalent	 proteins	 found	 in	 ENM-biocorona	 irrespective	 of	 ENM	
nature,	size,	and	shape.	Given	the	importance	of	ApoA-I	in	HDL	and	cholesterol	transport,	it	is	necessary	to	understand	the	
mechanisms	of	ApoA-I	 adsorption	 and	 the	 associated	 structural	 changes	 for	 assessing	 consequences	 of	 ENM	exposure.	
Here,	we	used	a	comprehensive	array	of	microscopic	and	spectroscopic	tools	to	elucidate	the	interactions	between	ApoA-I	
and	100	nm	Ag	nanoparticles	(AgNPs)	with	four	different	surface	functional	groups.	We	found	that	the	protein	adsorption	
and	secondary	structural	changes	are	highly	dependent	on	the	surface	functionality.	Our	electrochemical	studies	provided	
new	evidence	for	charge	transfer	interactions	that	influence	ApoA-I	unfolding.	While	the	unfolding	of	ApoA-I	on	AgNPs	did	
not	significantly	modify	their	cellular	uptake	and	short-term	cytotoxicity,	we	observed	that	it	strongly	altered	the	ability	of	
only	some	AgNPs	to	generate	reactive	oxygen	species	 in	macrophages.	Our	results	shed	new	light	on	the	 importance	of	
surface	functionality	and	charge	transfer	interactions	in	biocorona	formation.							
			
Introduction	
	
The	 sustainable	 implementation	 of	 engineered	 nanomaterials	
(ENMs)	in	biological	applications,	such	as	drug	delivery	and	imaging,	
requires	 a	 comprehensive	 understanding	 of	 complex	
transformations	 and	 interactions	 at	 the	 nano-bio	 interface	 [1–4].	
ENMs	are	known	to	rapidly	associate	with	a	variety	of	biomolecules	
(e.g.,	 proteins,	 amino	 acids,	 and	 lipids)	 in	 any	 biological	milieu	 to	
form	 a	 biocorona	 on	 their	 surface	 [5–12].	 The	 presence	 of	
biocorona	 on	 ENMs	 imparts	 a	 new	 distinctive	 interactive	 surface,	
which	ultimately	determines	the	biological	 implications	and	fate	of	
ENMs.	 	 Previous	 studies	 showed	 that	 ENM-biocorona	 (ENM-BC)	
leads	 to	 various	 physiological	 and	 pathological	 changes	 including	
protein	aggregation,	blood	coagulation,	and	complement	activation	
[5–12].			
Although	many	physicochemical	characteristics	of	ENMs	have	been	
reported	to	influence	ENM-BC,	it	is	not	yet	clear	what	combination	
of	these	properties	could	be	used	to	predict	ENM-BC	formation	and	
evolution	[13,	14].	The	composition	of	ENM-BC	is	known	to	strongly	
depend	on	ENM	size	and	surface	charge	[5,	6,	9–11,	15–21].		Larger	
ENMs	exhibit	a	preferential	adsorption	of	higher	molecular	weight	
proteins	 whereas	 lower	 molecular	 weight	 proteins	 accumulate	
more	on	 the	 surface	of	 smaller	ENMs.	On	 the	other	hand,	 surface	
charge	 is	 expected	 to	 be	 a	 key	 factor	 in	 determining	 protein	
structural	 changes	 [9,	 10,	 12–15,	 21].	 The	 interactions	 between	
ENM	 surface	 and	proteins	 could	 disrupt	 the	 structural	 integrity	 of	
proteins	 in	 ENM-BC	 and	 impact	 their	 function	 or	 elicit	 adverse	
immune	 responses.	 The	 surface	 coatings	 or	 functional	 groups	 are	
physically	 and	 chemically	 more	 active	 relative	 to	 the	 core	 of	 the	
ENM.	 For	 instance,	 citrate	 groups	 adsorbed	 on	 the	 surface	 of	 Ag	
nanoparticles	 (AgNPs)	 are	 negatively	 charged	 and	 provide	
electrostatic	repulsion	needed	to	prevent	AgNP	agglomeration.	Any	
oppositely	 charged	 biomolecules	 (compared	 to	 the	 surface	
functional	 groups	 on	 the	 ENM)	 experience	 a	 natural	 electrostatic	
attraction	 to	 adsorb	 on	 ENM	 surface.	 Proteins	 with	 a	 stronger	
affinity	 to	 the	 ENM	 core	 can	 quickly	 displace	 the	 initially	 present	
functional	 groups	 and	 be	 irreversibly	 immobilized	 on	 the	 ENM	
surface	 by	 partial	 or	 complete	 denaturation	 [13,	 15,	 22].	 	 A	
combination	 of	 many	 factors	 including	 van	 der	 Waals	 forces,	
hydrogen	 bridges,	 charge	 transfer	 and	 other	 hydrophobic	
interactions	are	known	to	drive	protein	denaturation	[23–26].	Such	
factors	naturally	depend	upon	ENM	physicochemical	properties.	 It	
is	 imperative	 to	 deconvolute	 the	 influence	 of	 different	
physicochemical	 properties	 (e.g.,	 surface	 charge	 and	 size)	 and	
understand	how	they	differ	 from	each	other	 in	 influencing	protein	
adsorption	and	denaturation	in	the	ENM-BC.		
Here,	we	experimentally	investigated	the	influence	of	AgNP	surface	
charges	 on	 adsorption	 and	 denaturation	 of	 apolipoprotein	 A-I	
(ApoA-I).	 Considering	 that	 ApoA-I	 is	 one	 of	 the	 most	 abundant	
proteins	in	AgNP-BC	irrespective	of	AgNP	size	[20],	its	adsorption	on	
AgNPs	 with	 different	 surface	 coatings	 could	 provide	 new	 insights	
into	 the	 role	 of	 surface	 charges	 in	 ENM-BC.	 	 ApoA-I	 is	 the	major	
lipoprotein	component	of	high-density	lipoprotein	(HDL).	It	adopts	a	
shape	similar	to	a	horseshoe	of	dimensions	12.5x8x4	nm	with	high	
α-helix	 content	 [27–31].	 The	helices	 in	ApoA-I	 are	predicted	 to	be	
amphipathic,	 with	 the	 hydrophobic	 (/hydrophilic)	 face	 mediating	
lipid	(/aqueous)	interactions.	The	thermodynamic	drive	to	minimize	
		
the	 aqueous	 exposure	 of	 the	 hydrophobic	 residues	 is	 one	 of	 the	
major	 factors	 in	ApoA-I	 adsorption	on	AgNPs	 [32,	33].	We	studied	
the	 interactions	 between	 ApoA-I	 and	 100	 nm	 AgNPs	 with	 four	
different	coatings	viz.,	citrate,	polyvinylpyrrolidone	(PVP),	branched	
polyethylenimine	(bPEI)	and	lipoic	acid.	These	coatings	were	chosen	
to	 provide	 both	 negative	 (citrate,	 PVP,	 lipoic	 acid)	 and	 positive	
charged	 surfaces	 (bPEI)	 with	 different	 affinities	 for	 AgNPs.	 While	
lipoic	 acid	 interacts	 strongly	 through	 Ag-S	 bonds,	 other	 coatings	
(citrate,	 PVP,	 bPEI)	 are	 considerably	 weaker.	 Our	 light	 scattering	
and	 surface	 charge	 studies	 on	 100	 nm	 AgNPs	 revealed	 that	 the	
binding	of	ApoA-I	on	AgNPs	is	sensitive	to	their	surface	charge	and	
functionality.	 	 While	 ApoA-I	 exhibited	 strong	 affinity	 for	 both	
positively	 and	 negatively	 charged	 AgNPs,	 its	 secondary	 structure	
exhibited	more	pronounced	changes	for	two	surface	functionalities	
viz.,	 lipoic	 acid	 and	 bPEI.	 In	 this	 article,	 we	 explain	 the	 observed	
secondary	 structural	 changes	 in	 terms	 of	 the	 electronic	 charge	
transfer,	 gleaned	 from	 electrochemical	 cyclic	 voltammetry	
experiments,	between	ApoA-I	and	functionalized	AgNPs.	Lastly,	the	
displacement	 of	 positively	 charged	 bPEI	 by	 ApoA-I	 and	 the	
structural	 changes	 of	 ApoA-I	 on	 AgNP-lipoic	 acid	 were	 found	 to	
induce	 a	 significant	 increase	 in	 their	 ability	 to	 generate	 reactive	
oxygen	species	(ROS).	Our	results	provide	new	insights	into	the	role	
of	AgNPs	surface	charge	in	ENM-BC	formation	and	its	 influence	on	
bio-response.		
Experimental	methods	
Aqueous	solution	of	AgNPs	(100nm,	NanoXact,	Nanocomposix)	with	
citrate,	 polyvinylpyrrolidone	 (PVP),	 branched	 polyethylenimine	
(bPEI)	 and	 lipoic	 acid	 as	 capping	 agents	 were	 purchased.	 ApoA-I	
from	human	plasma	 (MW	=	 28.3KDa)	was	 purchased	 from	 Sigma-
Aldrich.	 	 AgNPs	 (50	 μM)	 incubated	 overnight	 in	 different	 ApoA-I	
concentrations	 (0-4	 g/L)	 were	 utilized	 to	 study	 hydrodynamic	 size	
and	 zeta	 potential	 using	 Zetasizer	 Nano	 ZS90	 (Malvern	
Instruments).	 For	 transmission	 electron	 microscopy	 (TEM)	
characterization	 of	 the	 corona	 formation,	 AgNPs	 with	 ApoA-I	
biocorona	 were	 stained	 with	 0.1%	 osmium	 tetroxide	 (OsO4)	 by	
incubating	for	30	minutes.	These	samples	were	then	drop	casted	on	
400	mesh	Cu	grid	and	TEM	images	were	acquired	using	a	Hitachi	H-
7600	microscope.		
Electrochemical	 studies	 were	 performed	 using	 a	 Gamry	 reference	
3000	 electrochemical	 system.	 Cyclic	 voltammetry	 (CV)	
measurements	 were	 obtained	 in	 a	 three-electrode	 setup	 with	
Ag/AgCl	 as	 the	 reference	 electrode,	 platinum	 wire	 as	 the	
auxillary/counter	 electrode,	 and	 AgNPs	 as	 the	 working	 electrode.	
We	used	ApoA-I	solution	as	the	electrolyte	to	study	charge	transfer.	
It	should	be	noted	that	we	used	concentration	ranges	based	on	the	
physiological	 levels	 of	 ApoA-I	 (~1-1.3	 g/L)	 for	 electrochemical	
studies	to	avoid	high	current	values	that	could	result	 in	artifacts	 in	
charge	transfer	measurements.		
Circular	Dichroism	(CD)	measurements	were	performed	using	Jasco	
spectropolarimeter	 (J-810)	 to	 analyze	 secondary	 structures	 of	
ApoA-I	(300	μM)	after	the	biocorona	formation	on	AgNPs	(50	μM).		
Samples	were	prepared	for	CD	analysis	with	suspensions	of	AgNPs	
and	ApoA-I	corresponding	to	molar	ratio	of	1:600	and	incubated	at	
40	oC	for	8h.	The	CD	spectra	were	measured	at	room	temperature	
with	 wavelength	 range	 from	 200-300nm	 for	 all	 the	 samples	 at	 a	
scan	 speed	of	50nm/min.	Background	correction	was	applied	with	
pure	AgNP	suspension.		
Reactive	 oxygen	 species	 (ROS)	 were	 evaluated	 in	 RAW264.7	
macrophages	using	dichlorofluorescein	(DCF)	via	flow	cytometry	(by	
counting	10000	cells	per	sample	using	an	Accuri	C6	flow	cytometer).	
Macrophages	were	grown	to	90%	confluence	in	RPMI	1640	medium	
and	exposed	 to	30	μg/mL	of	AgNPs	 for	1h	 in	 serum	free	media	 to	
prevent	any	additional	biocorona	formation.	All	the	measurements	
were	performed	in	triplicates.		
	
Results	and	discussion	
	
As	 shown	 in	 Fig.	 1,	 TEM	 images	 confirmed	 that	 all	 four	 types	 of	
AgNPs	 (citrate,	PVP,	bPEI,	 and	 lipopic	acid	 coated)	are	 spherical	 in	
shape	with	a	similar	size	~100	nm	in	their	dehydrated	state.	ApoA-I	
appeared	 to	 non-uniformly	 adsorb	 on	 to	 AgNPs	 (Figs.	 1e-h)	 with	
strong	 preference	 for	 rough	 edges	 (see	 Figs.	 1f	 and	 h	 and	
supplementary	 Figs.	 S1-S4).	 	 Given	 the	 small	 size	 of	 ApoA-I	
(hydrodynamic	 size	 ~	 8	 nm)	 relative	 to	 100	 nm	 AgNPs,	 the	
biocorona	 possibly	 consisted	 of	 multiple	 ApoA-I	 layers.	 In	 some	
cases,	 ApoA-I	 was	 found	 to	 envelop	 AgNP	 aggregates	 in	 the	
dehydrated	 state	under	 TEM	 similar	 to	 previous	observations	 [37]	
(Figs.	S1-S4).			
Although	all	AgNPs	have	the	same	size	 in	their	dehydrated	size	(as	
evidenced	 by	 TEM),	we	 found	 that	 their	 hydrodynamic	 sizes	 (SHD)	
differed	 from	each	other	 in	 the	 following	order:	bPEI	 (~135	nm)	>	
PVP	(~120	nm)>lipoic	acid	(~108	nm)>	citrate	(~100	nm).	This	trend	
is	 expected	 based	 on	 the	 size	 of	 the	 surface	 coating	 molecules	
where	 polymers	 (bPEI	 and	 PVP)	 are	 significantly	 larger	 than	 the	
smaller	citrate	and	lipoic	acid	groups.	The	difference	in	the	surface	
coatings	 was	 also	 evident	 from	 their	 zeta	 potential	 (ζ)	
measurements	where	bPEI	is	positively	charged	with	a	relative	low	
ζ	 ~8.89	mV	while	 citrate	 (ζ∼−39 mV),	 PVP	 (ζ∼−37 mV),	 and	 lipoic	
acid	(ζ∼−28 mV)	exhibited	larger	negative	values.	Based	on	the	zeta	
potential	measurements,	negatively	charged	ApoA-I	(ζ∼−30−36 mV	
[37])	 is	 expected	 to	display	 strong	electrostatic	 attraction	 towards	
bPEI	 coated	 AgNPs	 and	 possibly	 experience	 some	 repulsion	 from	
other	negatively	charged	AgNPs.			
We	studied	the	evolution	of	SHD	and	ζ of	AgNPs	in	the	presence	of	
ApoA-I	(Figs.	2a	and	b).	In	the	case	of	bPEI,	ζ decreased	rapidly	and	
changed	from	a	positive	to	negative	value	in	the	presence	of	ApoA-
I.	 Indeed,	ζ values	 (~-24	mV)	 at	 higher	ApoA-I	 concentrations	 (>	2	
g/L)	 suggest	 that	 ApoA-I	 stabilized	 AgNPs	 better	 than	 bPEI.	 A	
concomitant	 decrease	 in	 SHD	 of	 AgNP-bPEI	 suggested	 that	 ApoA-I	
has	higher	affinity	for	AgNP	surface	and	ultimately	replaced	bPEI	on	
the	 AgNP	 surface.	 The	 surface	 potential	 of	 AgNP-PVP	 decreased	
with	 increasing	 concentration	of	ApoA-1	 similar	 to	bPEI.	However,	
		
SHD	showed	a	sharp	increase	with	a	rapid	saturation	at	relatively	low	
concentration	of	ApoA-I	 (<1	g/L).	Unlike	AgNP-bPEI	and	AgNP-PVP,	
a	significant	 increase	in	SHD	for	AgNP-lipoic	acid	was	observed	only	
at	higher	ApoA-I	 concentrations	 (>2	g/L).	The	observed	changes	 in	
both	 ζ and	 SHD	 were	 much	 slower	 for	 lipoic	 acid	 and	 can	 be	
rationalized	 in	 terms	of	 relatively	 strong	Ag-S	 interactions	 (binding	
energy	 ~217	 kJ/mol	 [38])	 between	 sulfur	 in	 lipoic	 acid	 and	 the	
surface	 of	 AgNPs.	 Interestingly,	 AgNP-citrate	 showed	 relatively	
smaller	 changes	 in	 SHD	 and	ζ compared	 to	 other	 surface	 coatings.	
Nevertheless,	 in	 all	 cases,	 the	 increase	 in	 SHD	 did	 not	 indicate	 the	
formation	 of	 AgNP	 aggregates	 unlike	 in	 the	 dehydrated	 state	 (cf.	
Figs.	 S1-S4).	 We	 found	 that	 the	 changes	 in	 SHD	 and	 ζ  saturated	
above	2	g/L	 for	all	 surface	coatings	excepting	bPEI	and	 lipoic	acid.	
While	 SHD	 for	 AgNP-lipoic	 acid	 appears	 saturated,	 its	 ζ did	 not	
suggest	 that	 protein	 adsorption	 was	 not	 saturated.	 	 When	 the	
average	 time	 between	 consecutive	 collisions	 (τc)	 of	 ApoA-I	 with	
AgNPs	 is	 greater	 than	 ApoA-I	 configurational	 relaxation	 time	 (τR),	
there	 is	 sufficient	 time	 for	 ApoA-I	 to	 unfold	 on	 the	 AgNP	 surface	
and	thus	could	form	a	disorganized	biocorona.	This	condition	(τc>τR)	
occurs	 at	 low	 ApoA-I	 concentrations	 (<2	 g/L)	 for	 AgNP-PVP	 and	
AgNP-citrate.	 Indeed,	 disorganized	 protein	 agglomerates	 can	 be	
clearly	observed	on	AgNP-PVP	surface	(Fig.	S2).	However,	at	higher	
τc	 ~τR,	 ApoA-I	 cannot	 completely	 unfold	 due	 to	 rapid	 collisions	
between	 ApoA-I	 and	 AgNPs.	 This	 results	 in	 a	 densely	 packed	
biocorona	 where	 ApoA-I	 retains	 much	 of	 its	 secondary	 structure.	
Based	on	the	results	described	in	Fig.	2,	it	may	be	expected	that	the	
biocorona	 layer	 present	 directly	 on	 the	 AgNP	 surface	 is	 densely	
packed	 at	 >	 2g/L	 for	 all	 cases	 excepting	 bPEI	 and	 lipoic	 acid,	 and	
thus	 saturates	 resulting	 in	 further	 changes	 in	 SHD	 and	 ζ .	 	 The	
collision	frequency	(fc=1/ τc)	of	ApoA-I	molecules	with	AgNP	surface	
may	be	calculated	using	the	Smoluchowski	equation	[39]	
fc=1/ τc	=2πDCdNA	 	 	 	 	 	 	 	 	 (1)	
where	D=	120	um2	s-1	is	the	room-temperature	diffusion	coefficient	
of	 the	 ApoA-I	 [40],	 d=	 12.8	 nm	 is	 the	 room-temperature	
hydrodynamic	diameter	of	ApoA-I	[41]	and	,	NA=6.023	×	10
23	mol-1	
is	 the	 Avogadro	 number,	 and	 C	 is	 ApoA-I	 concentration	 at	 which	
adsorption	saturates.	At	C=	2	g/L,	we	find	that	τc	~	90	µs,	which	 is	
on	 the	 same	 scale	 as	 protein	 unfolding	 timescales.	 	 It	 should	 be	
noted	 that	 the	 value	 of	 τc	 derived	 from	 the	 above	 analysis	 only	
provides	an	estimate	 for	 the	unfolding	 timescales.	Nevertheless,	 it	
could	 be	 used	 to	 infer	 that	 ApoA-I	 molecules	 will	 collide	 on	 a	
timescale	of	few	tens	of	µs	at	physiological	concentrations	~1.3-1.5	
g/L,	leading	to	a	rapid	saturation	in	adsorption	[42].		
It	is	well	known	that	some	proteins	change	their	conformation	upon	
binding	 to	 nanoparticle	 surfaces.	 Previously,	 Cukalevski	 et	 al.	
studied	 the	 conformational	 changes	 of	 ApoA-I	 on	 polystyrene	 (PS	
NPs)	 and	 NIPAM/BAM	 (N-isopropylacrylamide-co-N-tert-
butylacrylamide)	 small	 sized	 nanoparticles	 (<60	 nm)	 with	 large	
curvature	 and	 different	 surface	 charges	 [33].	 They	 found	 that	
uncoated	 and	 negatively	 charged	 PS	 NPs	 (diameter	 ~23-24	 nm)	
slightly	increased	helical	structure	of	ApoA-I	in	the	range	of	2-15	%	
whereas	 positively	 charged	 PS	 NPs	 	 (diameter	 ~57	 nm)	 slightly	
reduced	the	amount	of	helical	structure	by	~10%.	A	similar	study	by	
Li	et	 al.	 on	 30	 nm	negatively	 charged	AgNPs	 and	ApoA-I	 [37]	 also	
found	 reduction	 of	 helical	 content	 by	 ~15-20%.	 Although	 these	
previous	reports	provide	some	preliminary	understanding	of	ApoA-I	
interactions	with	ENMs,	a	controlled	study	with	AgNPs	of	same	size	
but	 different	 surface	 coatings	 is	 necessary	 to	 understand	 the	
influence	of	 surface	change.	 In	 this	 study,	we	used	100	nm	AgNPs	
with	different	 surface	 coatings	 to	 clearly	 distinguish	 the	 effects	 of	
surface	charges	and	understand	the	mechanisms	 involved	 in	ENM-
induced	protein	unfolding.	In	our	circular	dichroism	(CD)	studies,	we	
found	 that	 ApoA-I	 exhibited	 a	 significant	 decrease	 in	 the	 helical	
content	 by	 >40%	 on	 all	 100	 nm	 AgNPs.	 ApoA-I	 unfolding	 is	 more	
pronounced	 in	 our	 case	 due	 to	 the	 large	 AgNP	 size	 compared	 to	
previous	studies	[33,	37].	The	CD	spectra	revealed	that	the	changes	
in	helical	 content	were	more	prominent	 for	AgNP-bPEI	 and	AgNP-
lipoic	acid	compared	to	PVP	and	citrate	coatings.	Indeed,	the	helical	
content	of	ApoA-I	may	be	completely	 suppressed	 for	 these	AgNPs	
(Fig.	 3).	 These	 changes	 were	 accompanied	 by	 a	 concomitant	
increase	 in	 β-sheet	 and	 random	 chain	 structures	 in	 the	 following	
order:	AgNP-PVP<AgNP-citrate<AgNP-lipoic	acid~AgNP-bPEI.		
As	 shown	 in	 Fig.	 4,	 we	 performed	 cyclic	 voltammetry	 (CV)	 to	
develop	a	mechanistic	understanding	of	surface	charge	dependent	
conformational	changes	observed	in	CD	spectra	(Fig.	3).	To	this	end,	
AgNPs	 were	 immobilized	 on	 the	 glassy	 carbon	 working	 electrode	
and	 tested	 in	 ApoA-I	 solution	 as	 described	 in	 the	 experimental	
section.	 	 Proteins	 interact	 with	 ENM	 surfaces	 through	
intramolecular	bonds,	 ionic	bonds,	 and	 charge	 transfer	 [24,	 26].	A	
stabilizing	 charge	may	 be	 transferred	 between	 proteins	 and	 ENM	
surface	 depending	 upon	 their	 electronic	 energy	 levels,	 and	 the	
adsorbed	 proteins	 may	 undergo	 various	 conformational	 changes	
during	 the	 electron	 exchange	 process.	 Charge	 transfer	 processes	
and	 the	 relative	 differences	 between	 electronic	 energy	 levels	 of	
protein	 and	 ENM	 surface	 could	 be	 ascertained	 through	 peaks	 in	
current	(i.e.,	charge	flow)	during	a	CV	scan	[18,	39]	
In	the	CV	scan	of	AgNPs	without	ApoA-I	(dashed	lines	in	Fig.	4a),	we	
did	not	observe	any	peaks	for	all	four	surface	coatings.	The	addition	
of	 ApoA-I	 to	 the	 electrolyte	 resulted	 in	 a	 change	 in	 voltammetric	
responses	with	 the	appearance	of	a	new	peak	 (blue	arrows	 in	Fig.	
4a),	 which	 in	 turn	 increased	 the	 current	 considerably.	 This	 new	
peak	 cannot	 be	 attributed	 to	 desorption	 of	 adsorbed	 hydrogen	
(which	is	known	to	occur	~990	mV	vs.	Ag/AgCl	electrode	[39])	as	the	
peak	 appeared	 at	 appreciably	 low	 potentials	 <	 350	mV	 for	 all	 the	
coatings.	 We	 attribute	 this	 peak	 to	 stabilizing	 electron	 transfer	
between	 ApoA-I	 and	 AgNP	 surface.	 The	 electron	 transfer	 occurs	
only	when	the	electronic	energy	levels	of	ApoA-I	are	in	the	vicinity	
of	the	AgNP’s	energy	 levels.	The	so-called	Fermi	energy	(EF)	or	the	
chemical	potential	of	AgNPs	(that	serve	as	the	working	electrode	in	
our	CV	measurements)	 is	decreased	(/increased)	when	the	voltage	
in	a	CV	scan	is	increased	(/decreased).		An	electron	transfer	occurs	
when	the	energy	levels	of	ApoA-I	match	the	altered	EF	of	AgNPs	at	a	
particular	 voltage	 in	 the	 CV	 scan.	 This	 peak	 voltage	 for	 electron	
		
transfer	was	found	to	be	much	lower	for	AgNP-bPEI	and	AgNP-lipoic	
acid	(~60	mV)	compared	to	AgNP-citrate	and	AgNP-PVP	(~300	mV)	
suggesting	that	the	surface	coatings	have	considerable	influence	of	
electron	transfer	reactions	between	ApoA-I	and	AgNPs	(Fig.	4a).	The	
electrochemical	charge	transfer	(Q)	can	be	quantified	by	calculating	
the	 area	 enclosed	 by	 CV	 curves	 (Fig.	 4a).	 We	 found	 that	 all	 the	
AgNPs	 showed	 an	 increase	 in	 Q	 with	 increasing	 ApoA-I	
concentrations	 concurring	 with	 our	 hypothesis	 that	 the	 observed	
peak	arises	from	electron	transfer	between	ApoA-I	and	AgNPs.	The	
normalized	 area	 charge	 density	 (Q/cm2)	 at	 higher	 ApoA-I	
concentrations	 showed	 the	 following	 trend:	 AgNP-PVP>AgNP-
citrate>AgNP-lipoic	acid>AgNP-bPEI.	 This	 trend	appeared	 to	match	
the	changes	in	CD	spectra	described	earlier	in	Fig.	3.		
An	 interesting	 feature	 in	 the	 CV	 scans	 was	 the	 presence	 of	 an	
irreversible	charge	transfer	peak	for	AgNP-bPEI.	For	bPEI	coating,	a	
peak	was	observed	only	when	the	voltage	was	increasing	in	the	CV	
scan	 indicative	 of	 irreversible	 charge	 transfer.	On	 the	 other	 hand,	
CV	 scans	 for	 AgNP-citrate,	 AgNP-PVP,	 and	 AgNP-lipoic	 acid	
exhibited	an	observable	valley	(see	red	arrows	in	Fig.	4a)	during	the	
reverse	 voltage	 sweep	 suggesting	 that	 the	 observed	 Q	 for	 these	
coatings	 does	 not	 entirely	 result	 from	 irreversible	 charge	 transfer	
reaction.	 This	 reversible	 peak	 may	 possibly	 be	 attributed	 to	 the	
formation	of	hydrogen	bonds	between	ApoA-I	and	surface	coatings	
(PVP,	 citrate,	 and	 lipoic	 acid).	 Given	 that	 bPEI	 showed	 completely	
irreversible	 stabilizing	 charge	 transfer,	 we	 expect	 greater	
conformational	changes	in	ApoA-I.	In	other	words,	the	loss	of	ApoA-
I	 secondary	structure	on	bPEI	coated	AgNPs	precludes	 reversibility	
of	 charge	 transfer.	 Such	 an	 observation	 concurs	 with	 the	 CD	
spectra,	which	 showed	 complete	 loss	 of	α−helical	 content	 in	 bPEI	
coatings.	 It	 could	 be	 expected	 that	 the	 disruption	 of	 stabilizing	
hydrophobic	interactions	in	the	interior	of	the	protein	results	in	an	
irreversible	 charge	 transfer	 and	 ensues	 in	 ApoA-I	 structural	
relaxation	on	AgNP-bPEI.	On	the	other	hand,	AgNP-PVP	and	AgNP-
citrate	 facilitate	 hydrogen	 bond	 formation	 with	 substantial	
retention	of	 the	helical	 content.	Returning	 to	Fig.	3,	 the	 loss	 in	α-
helical	 content	 of	ApoA-I	 on	AgNP-lipoic	 acid	 cannot	 be	 explained	
based	 on	 charge	 transfer.	 It	 is	 possible	 that	 the	 ApoA-I	 molecule	
unfolds	on	AgNP-lipoic	acid	surface	to	 increase	 its	 interaction	with	
AgNP	 surface	 in	 order	 to	 break	 strong	 Ag-S	 interactions	 in	 AgNP-
lipoic	acid.		
	We	assessed	the	ability	of	AgNPs	with	and	without	ApoA-I	corona	
to	generate	 intracellular	ROS	 in	RAW	264.7	macrophages	after	1	h	
exposure	as	measured	by	DCF	fluorescence.		As	shown	in	Fig.	5,	we	
did	not	observe	any	significant	changes	(relative	to	control)	 in	ROS	
generation	 for	 pristine	 AgNPs	 without	 ApoA-I	 biocorona	
irrespective	of	 their	 surface	coatings.	However,	we	 found	 that	 the	
addition	of	ApoA-I	biocorona	changed	 the	 response	of	AgNP-bPEI-
ApoA-I	 relative	 to	 AgNP-bPEI	 without	 biocorona	 and	 AgNP-lipoic	
acid-ApoA-I	relative	to	the	control.	Based	on	our	CD	and	CV	results,	
we	 attribute	 these	 changes	 to	 the	 adsorption	 and	 unfolding	 of	
ApoA-I	on	AgNP-bPEI	and	AgNP-lipoic	acid.	Additionally,	AgNP-bPEI,	
ApoA-I	 biocorona	 resulted	 in	 an	 increased	 surface	 charge	
(accompanied	 by	 a	 change	 from	 positive	 to	 negative	 sign)	 and	
better	stability	(cf.	Fig.	2b)	that	could	have	also	been	a	contributing	
factor	 to	 the	 observed	 increase	 in	 ROS	 generation.	 Despite	 these	
changes	 in	 ROS	 generation,	 we	 did	 not	 observe	 any	 significant	
differences	 in	 the	 cytotoxicity	 of	 AgNPs	 before	 and	 after	 ApoA-I	
adsorption	(Fig.	S5).	Furthermore,	our	flow	cytometry	data	(Fig.	S6)	
did	 not	 show	 significant	 changes	 for	 AgNPs	 upon	 the	 addition	 of	
ApoA-I	biocorona.		Based	on	these	results	(Figs.	S5	and	S6),	changes	
in	 AgNP	 dissolution	 or	 uptake	 upon	 the	 addition	 of	 ApoA-I	
biocorona	 could	 be	 ruled	 out	 as	 possible	 cause	 for	 the	 observed	
differences	in	ROS	generation.	
Conclusions	
In	 summary,	our	dynamic	and	electrophoretic	 light	 scattering	
studies	showed	that	ApoA-I	displaces	surface	coatings	such	as	
citrate,	PVP,	and	bPEI	even	at	 low	concentrations	(<	2	g/L).	 In	
case	of	AgNP-lipoic	acid,	strong	Ag-S	interactions	inhibit	ApoA-I	
adsorption	 for	 concentrations	below	2	g/L.	Circular	dichroism	
studies	 showed	a	 significant	decrease	 in	α-helical	 content	 for	
all	 surface	 coatings	 with	 the	 complete	 disappearance	 of	
α−helices	 for	AgNP-bPEI	and	AgNP-lipoic	acid.	The	changes	 in	
secondary	structure	concur	with	the	observed	charge	transfer,	
measured	 using	 cyclic	 voltammetry,	 between	 ApoA-I	 and	
AgNPs.	The	unfolding	of	ApoA-I	on	AgNP-lipoic	acid	cannot	be	
completely	explained	in	terms	of	charge	transfer.	It	is	plausible	
that	ApoA-I	unfolds	on	the	surface	to	lower	its	free	energy	and	
thereby	 break	 strong	 Ag-S	 interactions	 in	 AgNP-lipoic	 acid.	
Lastly,	we	 found	a	 significant	 increase	 in	 the	ability	of	ApoA-I	
coated	 AgNP-bPEI	 and	 AgNP-lipoic	 acid	 to	 generate	 reactive	
oxygen	species,	which	can	be	attributed	to	changes	in	surface	
charge	and	the	unfolding	of	ApoA-I.	
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Figures	and	figure	captions:		
	
Figure	1:	Transmission	electron	micrographs	showing	as-purchased	
AgNPs	 (a-d)	 with	 citrate,	 PVP,	 bPEI	 and	 lipoic	 acid	 coatings	
respectively.	 The	 presence	 of	 biocorona	 (see	 arrows	 in	 e-h)	 upon	
incubation	with	ApoA-I	was	assessed	using	OsO4	staining	as	shown	
in	(e-h).	Scale	bar	is	100	nm.	
	
Figure	2:	(a)	The	hydrodynamic	size	of	AgNPs	was	found	to	change	
with	 increasing	 ApoA-I	 concentrations	 with	 saturation	 >2	 g/L	 for	
AgNP-PVP,	citrate,	and	lipoic	acid	coatings.	AgNP-bPEI,	however,	did	
not	 show	 such	 saturation.	 (b)	 The	 zeta	 potential	 measurements	
showed	 clear	 changes	 indicating	 the	 displacement	 of	 surface	
coatings	by	ApoA-I.	 All	 surface	 coatings	 showed	 saturation	 in	 zeta	
potential	 changes	 >2	 g/L	 excepting	 AgNP-lipoic	 acid.	 Based	 on	 (a)	
and	(b),	it	could	be	inferred	that	AgNP-bPEI	and	AgNP-lipoic	acid	do	
not	 show	 saturation	 in	 protein	 adsorption	 even	 at	 high	 ApoA-I	
concentrations.	 It	 should	 be	 noted	 that	 the	 physiological	
concentration	of	ApoA-I	is	1.3-1.5	g/L.		
	
	
	
	
	
Figure	3:	Circular	dichroism	spectra	for	ApoA-I	incubated	with	
AgNPs		(shown	in	the	inset)	of	different	surface	coatings	showed	
marked	decrease	in	helical	content	with	concomitant	increase	in	
beta	sheets	and	irregular	structures.		
	
	
Figure	4:	(a)	Cyclic	voltammetry	scans	showed	the	appearance	of	a	
peak	 (blue	 arrows)	 for	 AgNP	 electrodes	 in	 ApoA-I	 electrolyte	
suggesting	 the	presence	of	 charge-transfer	 stabilizing	 interactions.	
The	 peak	 for	 AgNP-bPEI	 occurred	 only	 in	 the	 forward	 scan	 (going	
from	 -0.4	 to	0.8	V)	 indicating	 irreversible	 charge	 transfer.	A	 valley	
(red	 arrows),	 representative	 of	 reversible	 charge	 transfer,	 was	
observed	for	other	surface	coatings	on	the	reverse	scan	(0.8	to	-0.4	
V).	 (b)	The	 total	charge	enclosed	by	 the	CV	curves	 in	 (a)	displayed	
clear	 increasing	 trends	 with	 ApoA-I	 concentration	 confirming	 that	
the	charge-transfer	occurs	due	to	interactions	between	ApoA-I	and	
AgNPs.		
	
	
	
		
	
						Figure	5:	DCF	assay	was	used	 to	evaluate	 the	ability	of	AgNPs	
with	 (+Apo)	 and	 without	 (-Apo)	 ApoA-I	 corona	 to	 generate	
reactive	 oxygen	 species	 (ROS).	 AgNP-bPEI-ApoA-I	 displayed	
significant	 increase	 in	 ROS	 generation	 compared	 to	AgNP-bPEI	
while	the	response	to	AgNP-lipoic	acid-ApoA-I	was	significantly	
higher	 than	 the	 control.	 These	 changes	may	 be	 attributed	 the	
protein	 unfolding	 observed	 in	 AgNP-bPEI	 and	 AgNP-lipoic	 acid	
(cf.	Fig.	3).	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
	
Supplementary	figures:	
	
																 	
Figure	 S1:	 Transmission	 electron	 micrographs	 showing	 ApoA-I	
corona	on	AgNPs	with	citrate.	Scale	bar	is	100	nm.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 S2:	 Transmission	 electron	 micrographs	 showing	 ApoA-I	
corona	 on	AgNPs	with	 polyvinylpyrrolidone	 (PVP).	 	 Scale	 bar	 is	
100	nm.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 S3:	 Transmission	 electron	 micrographs	 showing	 ApoA-I	
corona	on	AgNPs	with	 branched	polyethylenimine	 (bPEI).	 Scale	
bar	is	100	nm.	
	
	
	
	
	
	
	
	
	
Figure	 S4:	 Transmission	 electron	 micrographs	 showing	 ApoA-I	
corona	on	AgNPs	with	lipoic	acid.	Scale	bar	is	100	nm.	
